Adam de Havenon

Adam de Havenon, MD

Languages spoken: English, Spanish

Academic Information

Departments Adjunct - Neurology

Academic Office Information

Adam.DeHavenon@hsc.utah.edu

Board Certification

  • American Board of Psychiatry & Neurology (Neurology)
  • American Board of Psychiatry & Neurology (Sub: Vascular Neurology)
  • American Society of Neuroimaging (Neurosonology)

Dr. de Havenon is an Assistant Professor of Neurology at the University of Utah, School of Medicine. After receiving his B.A. from Yale University (New Haven, CT) in 2001, he received his medical degree from Brown University School of Medicine in 2009 (Providence, RI) and completed internship and neurology residency at the University of Utah in 2013. He finished a vascular neurology fellowship at University of Washington (Seattle, WA) in 2014, under the mentorship of Dr. David Tirschwell, where he also pursued additional training and certification in carotid and transcranial Doppler (TCD) ultrasound.

In July of 2014, Dr. de Havenon returned to Salt Lake City to establish his vascular neurology practice within the Stroke Center at the University of Utah. His clinical practice includes evaluating and treating acute strokes in the hospital and emergency department and providing outpatient consultation in the stroke clinic, including urgent referrals. He has a particular clinical interest in stroke in the young, intracranial atherosclerosis, optimizing secondary stroke risk factor reduction, vascular malformations such as aneurysms, and evaluating patients for interventional procedures such as carotid endarterectomy or stenting. He also provides emergency consultation to stroke patients at community hospitals via the University of Utah telestroke network.

Education History

Fellowship University of Washington
 Fellow
Residency University of Utah
 Resident
Internship University of Utah
 Intern
Professional Medical Alpert Medical , Brown University
 MD
Undergraduate Yale University
 BA

Selected Publications

Journal Article

  1. de Havenon A, Ney JP, Callaghan B, Delic A, Hohmann S, Shippey E, Esper GJ, Stulberg E, Tirschwell D, Frontera J, Yaghi S, Anadani M, Majersik JJ (2020). Impact of COVID-19 on Outcomes in Ischemic Stroke Patients in the United States. J Stroke Cerebrovasc Dis, 30(2), 105535. (Read full article)
  2. Yaghi S, Dehkharghani S, Raz E, Jayaraman M, Tanweer O, Grory BM, Henninger N, Lansberg MG, Albers GW, Havenon A (2020). The Effect of Hyperglycemia on Infarct Growth after Reperfusion: An Analysis of the DEFUSE 3 trial. J Stroke Cerebrovasc Dis, 30(1), 105380. (Read full article)
  3. Menacho ST, Grandhi R, Delic A, Anadani M, Ziai WC, Awad IA, Hanley DF, de Havenon A (2020). Impact of Intracranial Pressure Monitor-Guided Therapy on Neurologic Outcome After Spontaneous Nontraumatic Intracranial Hemorrhage. J Stroke Cerebrovasc Dis, 30(3), 105540. (Read full article)
  4. McNally JS, Havenon A, Kim SE, Wang C, Wang S, Zabriskie MS, Parker DL, Baradaran H, Alexander MD (2020). Rabbit models of intracranial atherosclerotic disease for pathological validation of vessel wall MRI. Neuroradiol J, 34(3), 1971400920980153. (Read full article)
  5. Katsanos AH, Alexandrov AV, Mandava P, Khrmann M, Soinne L, Barreto AD, Sharma VK, Mikulik R, Muir KW, Rothlisberger T, Grotta JC, Levi CR, Molina CA, Saqqur M, Palaiodimou L, Psaltopoulou T, Vosko MR, Moreira T, Fiebach JB, Rubiera M, Sandset EC, de Havenon A, Kent TA, Alexandrov AW, Schellinger PD, Tsivgoulis G, CLOTBUST-ER Trial Investigators (2020). Pulse pressure variability is associated with unfavorable outcomes in acute ischaemic stroke patients treated with intravenous thrombolysis. Eur J Neurol, 27(12), 2453-2462. (Read full article)
  6. Wong KH, Hu K, Peterson C, Sheibani N, Tsivgoulis G, Majersik JJ, de Havenon AH (2020). Diabetic Retinopathy and Risk of Stroke: A Secondary Analysis of the ACCORD Eye Study. Stroke, 51(12), 3733-3736. (Read full article)
  7. Zhou E, Lord A, Boehme A, Henninger N, de Havenon A, Vahidy F, Ishida K, Torres J, Mistry EA, Mac Grory B, Sheth KN, Gurol ME, Furie K, Elkind MSV, Yaghi S (2020). Risk of Ischemic Stroke in Patients With Atrial Fibrillation After Extracranial Hemorrhage. Stroke, 51(12), 3592-3599. (Read full article)
  8. Medicherla CB, Pauley RA, de Havenon A, Yaghi S, Ishida K, Torres JL (2020). Cerebral Venous Sinus Thrombosis in the COVID-19 Pandemic. J Neuroophthalmol, 40(4), 457-462. (Read full article)
  9. de Havenon A, Narata AP, Amelot A, Saver JL, Bozorgchami H, Mattle HP, Ribo M, Andersson T, Zaidat OO, ARISE II investigators (2020). Benefit of endovascular thrombectomy for M2 middle cerebral artery occlusion in the ARISE II study. J Neurointerv Surg. (Read full article)
  10. de Havenon A, Yaghi S, Mistry EA, Delic A, Hohmann S, Shippey E, Stulberg E, Tirschwell D, Frontera JA, Petersen NH, Anadani M (2020). Endovascular thrombectomy in acute ischemic stroke patients with COVID-19: prevalence, demographics, and outcomes. J Neurointerv Surg, 12(11), 1045-1048. (Read full article)
  11. Anadani M, Lapergue B, Blanc R, Kyheng M, Labreuche J, Machaa MB, Duhamel A, Marnat G, Saleme S, Costalat V, Bracard S, Anxionnat R, Spiotta AM, DeHavenon A, Richard S, Desal H, Mazighi M, Consoli A, Piotin M, Gory B (2020). Admission Blood Pressure and Outcome of Endovascular Therapy: Secondary Analysis of ASTER Trial. J Stroke Cerebrovasc Dis.
  12. Medicherla CB, Pauley RA, de Havenon A, Yaghi S, Ishida K, Torres JL (2020). Cerebral Venous Sinus Thrombosis in the Coronavirus Disease 2019 Pandemic. J Neuroophthalmol. (Read full article)
  13. Taussky P, Agnoletto G, Grandhi R, Alexander MD, Wong KH, Albers GW, de Havenon A (2020). Prediction of death after endovascular thrombectomy in the extended window: a secondary analysis of DEFUSE 3 ". J Neurointerv Surg, 13(9), 805-808. (Read full article)
  14. Frontera JA, Sabadia S, Lalchan R, Fang T, Flusty B, Millar-Vernetti P, Snyder T, Berger S, Yang D, Granger A, Morgan N, Patel P, Gutman J, Melmed K, Agarwal S, Bokhari M, Andino A, Valdes E, Omari M, Kvernland A, Lillemoe K, Chou SH, McNett M, Helbok R, Mainali S, Fink EL, Robertson C, Schober M, Suarez JI, Ziai W, Menon D, Friedman D, Friedman D, Holmes M, Huang J, Thawani S, Howard J, Abou-Fayssal N, Krieger P, Lewis A, Lord AS, Zhou T, Kahn DE, Czeisler BM, Torres J, Yaghi S, Ishida K, Scher E, de Havenon A, Placantonakis D, Liu M, Wisniewski T, Troxel AB, Balcer L, Galetta S (2020). A Prospective Study of Neurologic Disorders in Hospitalized COVID-19 Patients in New York City. Neurology. (Read full article)
  15. Anadani M, Arthur AS, Alawieh A, Orabi Y, Alexandrov A, Goyal N, Psychogios MN, Maier I, Kim JT, Keyrouz SG, de Havenon A, Petersen NH, Pandhi A, Swisher CB, Inamullah O, Liman J, Kodali S, Giles JA, Allen M, Wolfe SQ, Tsivgoulis G, Cagle BA, Oravec CS, Gory B, De Marini P, Kan P, Rahman S, Richard S, Nascimento FA, Spiotta A (2019). Blood pressure reduction and outcome after endovascular therapy with successful reperfusion: a multicenter study. J Neurointerv Surg, 12(10), 932-936. (Read full article)
  16. Anadani M, de Havenon A, Yaghi S, Mehta T, Arora N, Starosciak AK, De Los Rios La Rosa F, Siegler J, Mistry AM, Chitale R, Spiotta AM, Tsivgoulis G, Khatri P, Mistry EA (2020). Blood pressure reduction and outcome after endovascular therapy: a secondary analysis of the BEST study. J Neurointerv Surg. (Read full article)
  17. Yaghi S, Mistry E, Liberman AL, Giles J, Asad SD, Liu A, Nagy M, Kaushal A, Azher I, Mac Grory B, Fakhri H, Brown Espaillat K, Pasupuleti H, Martin H, Tan J, Veerasamy M, Esenwa C, Cheng N, Moncrieffe K, Moeini-Naghani I, Siddu M, Scher E, Trivedi T, Lord A, Furie K, Keyrouz S, Nouh A, Leon Guerrero CR, de Havenon A, Khan M, Henninger N (2020). Anticoagulation Type and Early Recurrence in Cardioembolic Stroke: The IAC Study. Stroke, 51(9), 2724-2732. (Read full article)
  18. Agarwal S, Scher E, Rossan-Raghunath N, Marolia D, Butnar M, Torres J, Zhang C, Kim S, Sanger M, Humbert K, Tanweer O, Shapiro M, Raz E, Nossek E, Nelson PK, Riina HA, de Havenon A, Wachs M, Farkas J, Tiwari A, Arcot K, Parella DT, Liff J, Wu T, Wittman I, Caldwell R, Frontera J, Lord A, Ishida K, Yaghi S (2020). Acute stroke care in a New York City comprehensive stroke center during the COVID-19 pandemic. J Stroke Cerebrovasc Dis, 29(9), 105068. (Read full article)
  19. Kvernland A, Kumar A, Yaghi S, Raz E, Frontera J, Lewis A, Czeisler B, Kahn DE, Zhou T, Ishida K, Torres J, Riina HA, Shapiro M, Nossek E, Nelson PK, Tanweer O, Gordon D, Jain R, Dehkharghani S, Henninger N, de Havenon A, Grory BM, Lord A, Melmed K (2020). Anticoagulation use and Hemorrhagic Stroke in SARS-CoV-2 Patients Treated at a New York Healthcare System. Neurocrit Care. (Read full article)
  20. Yaghi S, Liberman AL, Henninger N, Grory BM, Nouh A, Scher E, Giles J, Liu A, Nagy M, Kaushal A, Azher I, Fakhri H, Espaillat KB, Asad SD, Pasupuleti H, Martin H, Tan J, Veerasamy M, Esenwa C, Cheng N, Moncrieffe K, Moeini-Naghani I, Siddu M, Trivedi T, Ishida K, Frontera J, Lord A, Furie K, Keyrouz S, de Havenon A, Mistry E, Leon Guerrero CR, Khan M (2020). Factors associated with therapeutic anticoagulation status in patients with ischemic stroke and atrial fibrillation. J Stroke Cerebrovasc Dis, 29(7), 104888. (Read full article)
  21. de Havenon A, Khatri P, Prabhakaran S, Yeatts SD, Peterson C, Sacchetti D, Alexander M, Cutting S, Grory BM, Furie K, Liebeskind DS, Yaghi S (2020). Hypoperfusion Distal to Anterior Circulation Intracranial Atherosclerosis is Associated with Recurrent Stroke. J Neuroimaging, 30(4), 468-470. (Read full article)
  22. Yaghi S, Khatri P, de Havenon A, Yeatts S, Chang AD, Cutting S, Mac Grory B, Burton T, Jayaraman MV, McTaggart RA, Fiorella D, Derdeyn C, Zaidat OO, Dehkharghani S, Amin-Hanjani S, Furie K, Prahbakaran S, Liebeskind D (2019). Peri-procedural stroke or death in stenting of symptomatic severe intracranial stenosis. J Neurointerv Surg, 12(4), 374-379. (Read full article)
  23. Yaghi S, Cotsonis G, de Havenon A, Prahbakaran S, Romano JG, Lazar RM, Marshall RS, Feldmann E, Liebeskind DS (2020). Poststroke Montreal Cognitive Assessment and Recurrent Stroke in Patients With Symptomatic Intracranial Atherosclerosis. J Stroke Cerebrovasc Dis, 29(4), 104663. (Read full article)
  24. Flusty B, de Havenon A, Prabhakaran S, Liebeskind DS, Yaghi S (2020). Intracranial Atherosclerosis Treatment: Past, Present, and Future. Stroke, 51(3), e49-e53. (Read full article)
  25. Mistry EA, Mehta T, Mistry A, Arora N, Starosciak AK, De Los Rios La Rosa F, Siegler JE 3rd, Chitale R, Anadani M, Yaghi S, Khatri P, de Havenon A (2019). Blood Pressure Variability and Neurologic Outcome After Endovascular Thrombectomy: A Secondary Analysis of the BEST Study. Stroke, 51(2), 511-518. (Read full article)
  26. de Havenon A, Joyce E, Yaghi S, Ansari S, Delic A, Taussky P, Alexander M, Tirschwell D, Grandhi R (2019). End-of-Treatment Intracerebral and Ventricular Hemorrhage Volume Predicts Outcome: A Secondary Analysis of MISTIE III. Stroke, 51(2), 652-654. (Read full article)
  27. de Havenon A, Chung LS, Smith J, Taylor K, Majersik JJ, Chauhan N (2019). Less Experienced Telestroke Consultants Are More Likely to Go On-Camera, but Less Likely to Give tPA. Stroke Res Treat, 2019, 1059369. (Read full article)
  28. de Havenon A, Prabhakaran S, Turan T, Gottesman R, Yeatts S, Rost N (2019). Is There Equipoise Regarding the Optimal Medical Treatment of Patients with Asymptomatic White Matter Hyperintensities? J Stroke Cerebrovasc Dis, 28(11), 104371. (Read full article)
  29. de Havenon A, Fino NF, Johnson B, Wong KH, Majersik JJ, Tirschwell D, Rost N (2019). Blood Pressure Variability and Cardiovascular Outcomes in Patients With Prior Stroke: A Secondary Analysis of PRoFESS. Stroke, 50(11), 3170-3176. (Read full article)
  30. de Havenon A (2019). Blood pressure variability: An emerging target for risk reduction in the setting of hypertensive emergency. J Clin Hypertens (Greenwich), 21(11), 1693-1694. (Read full article)
  31. de Havenon A, Muhina HJ, Parker DL, McNally JS, Alexander MD (2019). Effect of Time Elapsed since Gadolinium Administration on Atherosclerotic Plaque Enhancement in Clinical Vessel Wall MR Imaging Studies. AJNR Am J Neuroradiol, 40(10), 1709-1711. (Read full article)
  32. Sultan-Qurraie A, Witt T, de Havenon A, Ribo M, Zaidat OO (2019). SEIMLESS: Simultaneous Extracranial, Intracranial Management of (tandem) LESsions in Stroke. J Neurointerv Surg, 11(9), 879-883. (Read full article)
  33. de Havenon A, Wong KH, Elkhetali A, McNally JS, Majersik JJ, Rost NS (2019). Carotid Artery Stiffness Accurately Predicts White Matter Hyperintensity Volume 20 Years Later: A Secondary Analysis of the Atherosclerosis Risk in the Community Study. AJNR Am J Neuroradiol, 40(8), 1369-1373. (Read full article)
  34. de Havenon A, Meyer C, McNally JS, Alexander M, Chung L (2019). Subclinical Cerebrovascular Disease: Epidemiology and Treatment. Curr Atheroscler Rep, 21(10), 39. (Read full article)
  35. Zaidat OO, Changal KH, Sultan-Qurraie A, de Havenon A, Calderon VJ, Goins-Whitmore J, Patterson MS, Lin E (2019). Diurnal Variations in the First 24/7 Mobile Stroke Unit. Stroke, 50(7), 1911-1914. (Read full article)
  36. de Havenon A, Stoddard G, Saini M, Wong KH, Tirschwell D, Bath P, VISTA-Acute Collaborators (2019). Increased blood pressure variability after acute ischemic stroke increases the risk of death: A secondary analysis of the Virtual International Stroke Trial Archive. JRSM Cardiovasc Dis, 8, 2048004019856496. (Read full article)
  37. Alexander MD, de Havenon A, Kim SE, Parker DL, McNally JS (2019). Assessment of quantitative methods for enhancement measurement on vessel wall magnetic resonance imaging evaluation of intracranial atherosclerosis. Neuroradiology, 61(6), 643-650. (Read full article)
  38. de Havenon A, Majersik JJ, Tirschwell DL, McNally JS, Stoddard G, Rost NS (2019). Blood pressure, glycemic control, and white matter hyperintensity progression in type 2 diabetics. Neurology, 92(11), e1168-e1175. (Read full article)
  39. de Havenon A, Mlynash M, Kim-Tenser MA, Lansberg MG, Leslie-Mazwi T, Christensen S, McTaggart RA, Alexander M, Albers G, Broderick J, Marks MP, Heit JJ, DEFUSE 3 Investigators (2019). Results From DEFUSE 3: Good Collaterals Are Associated With Reduced Ischemic Core Growth but Not Neurologic Outcome. Stroke, 50(3), 632-638. (Read full article)
  40. McNally JS, Hinckley PJ, Sakata A, Eisenmenger LB, Kim SE, De Havenon AH, Quigley EP, Iacob E, Treiman GS, Parker DL (2018). Magnetic Resonance Imaging and Clinical Factors Associated With Ischemic Stroke in Patients Suspected of Cervical Artery Dissection. Stroke, 49(10), 2337-2344. (Read full article)
  41. Bennett AE, Wilder MJ, McNally JS, Wold JJ, Stoddard GJ, Majersik JJ, Ansari S, de Havenon A (2018). Increased blood pressure variability after endovascular thrombectomy for acute stroke is associated with worse clinical outcome. J Neurointerv Surg, 10(9), 823-827. (Read full article)
  42. de Havenon A, Majersik JJ, Stoddard G, Wong KH, McNally JS, Smith AG, Rost NS, Tirschwell DL (2018). Increased Blood Pressure Variability Contributes to Worse Outcome After Intracerebral Hemorrhage. Stroke, 49(8), 1981-1984. (Read full article)
  43. Athiraman U, Sultan-Qurraie A, Nair B, Tirschwell DL, Ghodke B, Havenon AD, Hallam DK, Kim LJ, Becker KJ, Sharma D (2017). Endovascular Treatment of Acute Ischemic Stroke Under General Anesthesia: Predictors of Good Outcome. J Neurosurg Anesthesiol, 30(3), 223-230. (Read full article)
  44. Ravindra VM, de Havenon A, Gooldy TC, Scoville J, Guan J, Couldwell WT, Taussky P, MacDonald JD, Schmidt RH, Park MS (2017). Validation of the unruptured intracranial aneurysm treatment score: comparison with real-world cerebrovascular practice. J Neurosurg, 129(1), 100-106. (Read full article)
  45. Peckham ME, Anderson JS, Rassner UA, Shah LM, Hinckley PJ, de Havenon A, Kim SE, McNally JS (2018). Low b-value diffusion weighted imaging is promising in the diagnosis of brain death and hypoxic-ischemic injury secondary to cardiopulmonary arrest. Crit Care, 22(1), 165. (Read full article)
  46. Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, et al, DEFUSE 3 Investigators (01/24/2018). Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. (member of DEFUSE 3 investigators). N Engl J Med.
  47. de Havenon AH, Mossa-Basha M, Shah L, Kim SE, Park M, Parker D, McNally S (12/01/2017). High-Resolution Vessel Wall MRI for the Evaluation of Intracranial Atherosclerotic Disease. Neuroradiology, 59(12), 1193-1202.
  48. Guan J, McNally S, de Havenon A, Kalani MYS, Taussky P, Kim S, Park MS (12/01/2017). High-Resolution Magnetic Resolution Imaging of Intracranial Aneurysms Treated by Flow Diversion. Interdiscip Neurosurg, 10(12), 69-74.
  49. Mossa-Basha M, Shibata DK, Hallam DK, de Havenon A, Hippe DS, Becker KJ, Tirschwell DL, Hatsukami T, Balu N, Yuan C (2017). Added Value of Vessel Wall Magnetic Resonance Imaging for Differentiation of Nonocclusive Intracranial Vasculopathies. Stroke, 48(11), 3026-3033. (Read full article)
  50. de Havenon A, Tirschwell D, Majersik JJ, McNally S, Stoddard G, Moore A, Mossa-Basha M (2017). Carotid intraplaque hemorrhage on vessel wall MRI does not correlate with TCD emboli monitoring in patients with recently symptomatic carotid atherosclerosis. Neuroradiol J, 30(5), 486-489. (Read full article)
  51. Sharma D, Athiraman U, Sultan-Qurraie A, nair B, Tirschwell D, Ghodke B, de Havenon A, Hallam D, Kim L, Becker K (07/31/2017). Endovascular Treatmetn of Acute Ischemic Stroke Under General Anesthesia: Predictors of a Good Outcome. J Neurosurg Anesthesiol.
  52. de Havenon A, Haynor DR, Tirschwell DL, Majersik JJ, Smith G, Cohen W, Andre JB (2017). Association of Collateral Blood Vessels Detected by Arterial Spin Labeling Magnetic Resonance Imaging With Neurological Outcome After Ischemic Stroke. JAMA Neurol, 74(4), 453-458. (Read full article)
  53. McNally JS, Kim SE, Mendes J, Hadley JR, Sakata A, De Havenon AH, Treiman GS, Parker DL (2017). Magnetic Resonance Imaging Detection of Intraplaque Hemorrhage. Magn Reson Insights, 10, 1-8. (Read full article)
  54. de Havenon A, Bennett A, Stoddard GJ, Smith G, Chung L, ODonnell S, McNally JS, Tirschwell D, Majersik JJ (2017). Determinants of the impact of blood pressure variability on neurological outcome after acute ischaemic stroke. Stroke Vasc Neurol, 2(1), 1-6. (Read full article)
  55. Bennett A, Wold J, de Havenon A (2016). Treatment of Carotid Intramural Thrombus With TPA. JAMA Neurol, 73(12), 1496. (Read full article)
  56. Samara VC, de Havenon A (2016). Rare case of T-cell lymphoma presenting as acute myelopathy. BMJ Case Rep, 2016. (Read full article)
  57. de Havenon A, Park M, McNally S (2016). Vessel wall MRI of an inflamed aneurysm with atherosclerosis in a patient with ischemic stroke. Neurology, 87(7), 741-2. (Read full article)
  58. Eisenmenger LB, Aldred BW, Kim SE, Stoddard GJ, de Havenon A, Treiman GS, Parker DL, McNally JS (2016). Prediction of Carotid Intraplaque Hemorrhage Using Adventitial Calcification and Plaque Thickness on CTA. AJNR Am J Neuroradiol, 37(8), 1496-503. (Read full article)
  59. Mossa-Basha M, de Havenon A, Becker KJ, Hallam DK, Levitt MR, Cohen WA, Hippe DS, Alexander MD, Tirschwell DL, Hatsukami T, Amlie-Lefond C, Yuan C (2016). Added Value of Vessel Wall Magnetic Resonance Imaging in the Differentiation of Moyamoya Vasculopathies in a Non-Asian Cohort. Stroke, 47(7), 1782-8. (Read full article)
  60. de Havenon A, Chung LS, Park M, Mossa-Basha M (06/02/2016). Intracranial Vessel Wall Imaging with High-Resolution MRI: a review of current indications and future applications. Neurovasc Imaging, 2(10).
  61. Chung LS, Tkach A, Lingenfelter EM, Dehoney SB, Rollo J, de Havenon A, DeWitt LD, Grantz MR, Wang H, Wold JJ, Hannon PM, Weathered NR, Majersik JJ (2016). Tissue Plasminogen Activator Prescription and Administration Errors within a Regional Stroke System. J Stroke Cerebrovasc Dis, 25(3), 565-71. (Read full article)
  62. de Havenon A, Bennett A, Stoddard GJ, Smith G, Wang H, Wold J, Chung L, Tirschwell DL, Majersik JJ (2016). Increased Blood Pressure Variability Is Associated with Worse Neurologic Outcome in Acute Anterior Circulation Ischemic Stroke. Stroke Res Treat, 2016, 7670161. (Read full article)
  63. de Havenon A, Sultan-Qurraie A, Tirschwell D, Cohen W, Majersik J, Andre JB (2015). Medial Occipital Lobe Hyperperfusion Identified by Arterial Spin-Labeling: A Poor Prognostic Sign in Patients with Hypoxic-Ischemic Encephalopathy. AJNR Am J Neuroradiol, 36(12), 2292-5. (Read full article)
  64. de Havenon A, Moore A, Sultan-Qurraie A, Majersik JJ, Stoddard G, Tirschwell D (2015). Ischemic stroke patients with active malignancy or extracardiac shunts are more likely to have a right-to-left shunt found by TCD than echocardiogram. Transl Stroke Res, 6(5), 361-4. (Read full article)
  65. de Havenon A, Petersen C, Tanana M, Wold J, Hoesch R (2015). A pilot study of audiovisual family meetings in the intensive care unit. J Crit Care, 30(5), 881-3. (Read full article)
  66. Mossa-Basha M, Hwang WD, De Havenon A, Hippe D, Balu N, Becker KJ, Tirschwell DT, Hatsukami T, Anzai Y, Yuan C (2015). Multicontrast high-resolution vessel wall magnetic resonance imaging and its value in differentiating intracranial vasculopathic processes. Stroke, 46(6), 1567-73. (Read full article)
  67. de Havenon A, Sultan-Qurraie A, Hannon P, Tirschwell D (2015). Development of regional stroke programs. Curr Neurol Neurosci Rep, 15(5), 544. (Read full article)
  68. de Havenon A, Yuan C, Tirschwell D, Hatsukami T, Anzai Y, Becker K, Sultan-Qurraie A, Mossa-Basha M (2015). Nonstenotic Culprit Plaque: The Utility of High-Resolution Vessel Wall MRI of Intracranial Vessels after Ischemic Stroke. Case Rep Radiol, 2015, 356582. (Read full article)
  69. de Havenon A, Joos Z, Longenecker L, Shah L, Ansari S, Digre K (2014). Posterior reversible encephalopathy syndrome with spinal cord involvement. Neurology, 83(22), 2002-6. (Read full article)
  70. Doll ES, Bonkowsky JL, Brown LL, de Havenon AH, Brockmeyer DL, Glasgow TS, Morita DC (2014). Chiari I Malformation Causing Developmental Regression in a 4 Month Old. Glob Pediatr Health, 1, 2333794X14560819. (Read full article)
  71. French KF, Martinez JK, DeHavenon AH et al (2014). Reproducibility of ABC/2 method to determine infarct volume and mismatch percentage with CT perfusion. J Neuroimaging, 24(3), 232-7.
  72. de Havenon A, Davis G, Hoesch R (2014). Splenic rupture associated with primary CMV infection, AMSAN, and IVIG. J Neuroimmunol, 272(1-2), 103-5. (Read full article)
  73. French KF, Martinez JK, DeHavenon AH, Weathered NR, Grantz M, Smith SM, Wilder M, Rassner UA, Kircher JC, Dewitt LD, Wold JJ, Hoesch RE (2013). Reproducibility of ABC/2 method to determine infarct volume and mismatch percentage with CT perfusion. J Neuroimaging, 24(3), 232-7. (Read full article)
  74. de Havenon A, French K, Ansari S (2014). Extensive cortical diffusion restriction in a 50-year-old female with hyperammonemic encephalopathy and status epilepticus. Case Rep Neurol Med.
  75. de Havenon A, Ansari S (2014). Combating performance enhancing drug abuse: detection and punishment are not enough. Perform Enhanc Health, 3(1), 51-53.
  76. de Havenon A, French K, Ansari S (2014). Extensive cortical diffusion restriction in a 50-year-old female with hyperammonemic encephalopathy and status epilepticus. Case Rep Neurol Med, 2014, 257094. (Read full article)
  77. de Havenon A, Chin B, Thomas KC, Afra P (2011). The secret "spice": an undetectable toxic cause of seizure. Neurohospitalist, 1(4), 182-6. (Read full article)
  78. de Havenon A, Ehrenkranz J (2011). A perforated diverticulum in Cushing's disease. Int J Surg Case Rep, 2(7), 215-7. (Read full article)

Review

  1. Kilburg C, Scott McNally J, de Havenon A, Taussky P, Kalani MY, Park MS (2017). Advanced imaging in acute ischemic stroke. [Review]. Neurosurg Focus, 42(4), E10. (Read full article)

Case Report

  1. Chen R, Singh G, McNally JS, Palmer CA, de Havenon A (2020). Intravascular Lymphoma with Progressive CNS Hemorrhage and Multiple Dissections. Case Rep Neurol Med, 2020, 6134830. (Read full article)
  2. de Havenon A, Perez F, Andre J (2015). Regional arterial spin labelling hyperperfusion following incomplete hanging. AJNR Am J Neuroradiol.

Editorial

  1. Kalra L, de Havenon A (2019). Mental illness, implicit attitudes, and disparity of carotid revascularization after stroke. Neurology, 92(22), 1033-1034. (Read full article)
  2. de Havenon A, Southerland AM (2018). In large vessel occlusive stroke, time is brain… but collaterals are time. Neurology, 90(4), 153-154. (Read full article)

Letter

  1. Peterson C, Wong KH, Stulberg EL, Taylor K, Cramer SC, de Havenon AH (2021). Effect of Premorbid Anxiolytic Medications on Ischemic Stroke Functional Outcome. [Letter to the editor]. Stroke, STROKEAHA120032812. (Read full article)
  2. de Havenon A, Ney JP, Callaghan B, Yaghi S, Majersik JJ (2020). Excess neurological death in New York City after the emergence of COVID-19. [Letter to the editor]. J Neurol, 268(6), 2026-2028. (Read full article)
  3. Alexander MD, de Havenon A, Mossa-Basha M, McNally JS (2020). How Far Can We Take Vessel Wall MRI for Intracranial Atherosclerosis? The Tissue is Still the Issue. [Letter to the editor]. AJNR Am J Neuroradiol, 41(5), E30-E31. (Read full article)
  4. Kvernland A, Yaghi S, de Havenon A (2019). Letter by Kvernland et al Regarding Article, "Stroke Mechanisms in Symptomatic Intracranial Atherosclerotic Disease: Classification and Clinical Implications". [Letter to the editor]. Stroke, 50(12), e436. (Read full article)
  5. de Havenon A, Albers GW, Heit JJ (2019). Response by de Havenon et al to Letter Regarding Article, "Results From DEFUSE 3: Good Collaterals Are Associated With Reduced Ischemic Core Growth but Not Neurologic Outcome". [Letter to the editor]. Stroke, 50(6), e166. (Read full article)
  6. de Havenon A, McNally S (2016). Response to "High-Resolution Vessel Wall MRI: Appearance of Intravascular Lymphoma Mimics Central Nervous System Vasculitis". [Letter to the editor]. Clin Neuroradiol, 26(4), 501. (Read full article)
  7. Dehavenon A (2007). CT screening for lung cancer. [Letter to the editor]. N Engl J Med, 356(7), 745-6; author reply 746-7. (Read full article)

Abstract

  1. de Havenon A, ODonnell S, Linn A, McNally S, Dunleavy B, Majersik J (2017). A Simple Tool to Predict Target Mismatch in Ischemic Stroke Patients with Anterior Circulation Occlusion. Moderated Poster. [Abstract]. International StrokeConference.
  2. de Havenon A, Lobo R, Eisenmenger L, Chauhan N, Dewitt D, Kim S-E, et al (2017). MRI Detection of Vessel Wall Inflammation and Contrast Leakage in Cerebral Amyloid Angiopathy. Poster [Abstract]. International Stroke Conference.
  3. Linn AJ, ODonnell S, de Havenon A (2017). Comparison of Two Methods of the Alberta Stroke Program Early CT Score. Poster [Abstract]. International StrokeConference.
  4. ODonnell S, Linn A, Majersik J, Wang H, Chung L, de Havenon A (2107). Computed Tomography Angiography is Better at Predicting Lesion Core Volume in Acute Ischemic Stroke Patients with Proximal Occlusion. Poster [Abstract]. International StrokeConference.
  5. de Havenon A, Parker D, Kim S, Park M, McNally S (2016). Intracranial High-Resolution Vessel Wall MRI for the Detection of Arterial Inflammation, Unraveling Vascular Inflammation: From Inflammation to Imaging [Abstract]. NHLBI Symposium.
  6. Sultan-Qurraie A, de Havenon A, Lynch J, Fred-Fitzsimmons B (2016). Early Platelet Transfusion in Pateints with Subarachnoid Hemorrhage Does Not Improve Outcome. Poster [Abstract]. World Stroke Conference.
  7. de Havenon A, Tirschwell DL, Chung L, Wang H, Smith G, Majersik J (2016). Prediction of Neurologic Outcome after Ischemic Stroke with Volumetric Measurements on CT and MRI. Poster [Abstract]. International Stroke Conference.
  8. Bennett A, de Havenon A, Wilder M, Sultan-Qurraie A, Ansari A (2016). Determinants of Symptomatic Intracerebral Hemorrhage in Ischemic Stroke Patients After Endovascular Therapy. Moderated Poster [Abstract]. International Stroke Conference.
  9. Robb D, de Havenon A, Bennett A, Aitken K, Longbottom M, Brown R, MajersikJ (2016). American Indian Participation in Clinical Research: A Cultural Perspective Survey from a CREST-2 Site. Poster [Abstract]. International Stroke Conference.
  10. Dunleavy B, Chung L, Wang H, Majersik J, de Havenon A (2016). A Comparison of Automated and Manual Volumetric Analysis of CT Perfusion in Acute Ischemic Stroke Patients. Poster [Abstract]. International Stroke Conference.
  11. Bennett A, Wilder M, Majersik J, Ansari A, de Havenon A (2016). Increased Systolic Blood Pressure Variability is Associated with Symptomatic Intracerebral Hemorrhage After Endovascular Treatment for Stroke. Poster [Abstract]. InternationalStroke Conference.
  12. de Havenon A, ODonnell S, Wang H, Smith G, Majersik J (2016). A Comparison of Three Different CTA Collateral Scoring Systems’ Ability to Predict MR Lesion Volume and Outcome After Ischemic Stroke. E-Poster [Abstract]. American Academy ofNeurology Annual Meeting.
  13. Bennett A, Aitken K, Longbottom M, Brown R, de Havenon A, Majersik J, Robb D (2016). American Indian Participation in Clinical Research: A Cultural Perspective Survey from a CREST-2 Site. Poster [Abstract]. American Academy of Neurology Annual Meeting.
  14. ODonnell S, Majersik J, Smith G, Dunleavy B, de Havenon A (2016). CT-Based Collateral Scoring Can Predict Ischemic Penumbra Volume in Acute Ischemic Stroke. Poster [Abstract]. American Academy of Neurology Annual Meeting.
  15. Donleavy B, Chung L, Smith G, Majersik J, de Havenon A (2016). A Comparison Of Automated And Manual Volumetric Analysis Of Ct Perfusion In Acute Ischemic Stroke Patients. Poster [Abstract]. International Stroke Conference.
  16. Bennett A, Wilder M, Majersik J, Ansari S, de Havenon A (2016). Increased Systolic Blood Pressure Variability is Associated with Symptomatic Intracerebral Hemorrhage after Endovascular Treatment for Stroke. Moderated poster session [Abstract]. International Stroke Conference.
  17. Bennett A, de Havenon A, Wilder M, Sultan-Qurraie A, Ansari S (2016). Determinants of Symptomatic Intracerebral Hemorrhage in Ischemic Stroke Patients after Endovascular Therapy. Poster [Abstract]. International Stroke Conference.
  18. de Havenon A, Tirschwell DL, Sultan-Qurraie A, Jalal A (2015). Arterial Spin Labeling MRI Identifies Ischemic Stroke Patients with Good Outcome at Hospital Discharge. Poster [Abstract]. International Stroke Conference.
  19. de Havenon A, Tirschwell DL, Anzai Y et al (2014). Medial occipital lobe hyperperfusion – a poor prognostic sign for patients with hypoxic-anoxic injury. Poster [Abstract]. Radiological Society of North America Annual Meeting.
  20. Mossa-Basha M, Ferndale M, Hwang W, Hatsukami T, de Havenon A et al (2014). The Value of High-Resolution T2-Weighted Vessel Wall MR Imaging for the Differentiation of Intracranial Vasculopathies. Oral abstract [Abstract]. Radiological Society of North America Annual Meeting.
  21. de Havenon A, Sultan-Qurraie A, Moore A, Tirschwell D (2014). A Comparison of Transcranial Doppler to Echocardiography for the Detection of Right-to-left Shunt in Ischemic Stroke Patients. Poster [Abstract]. European Stroke Conference.
  22. Sultan-Qurraie A, de Havenon A, Tirschwell DL et al (2014). Performance Metrics for The Interventional Treatment Of Acute Ischemic Stroke: Results from A Comprehensive Stroke Center. Moderated poster [Abstract]. American Academy of Neurology Annual Meeting.
  23. Longenecker L, de Havenon A, Joos Z et al (2014). Two Case Reports of Posterior Reversible Encephalopathy Syndrome (PRES) Involving the Spinal Cord. Oral presentation [Abstract]. American Society of Spine Radiology Annual Symposium.
  24. de Havenon A, Joos Z, Longenecker L et al (2014). A Hypertensive Reversible Encephalomyelitis Syndrome (HyRES). Poster [Abstract]. International Stroke Conference.
  25. Sultan-Qurraie S, de Havenon A, Becker K et al (2014). Improved Ischemic Stroke Outcomes After Intra-arterial Interventions Associated with Higher HDL Cholesterol. Poster [Abstract]. International Stroke Conference.

Other

  1. Frontera JA, Rahimian JO, Yaghi S, Liu M, Lewis A, de Havenon A, Mainali S, Huang J, Scher E, Wisniewski T, Troxel AB, Meropol S, Balcer LJ, Galetta SL (2020). Treatment with Zinc is Associated with Reduced In-Hospital Mortality Among COVID-19 Patients: A Multi-Center Cohort Study. Res Sq. United States. (Read full article)
  2. de Havenon A (2013). Appearances on Salt Lake City NBC and ABC affiliates to discuss neurologic illness associated with drug use.

Video/Film/CD/Web/Podcast

  1. de Havenon A (2013-present). Monthly contributions to the American Heart Association’s “Blogging Stroke” website [Web]. Available: http://strokeblog.strokeahajournal.org.